Alan Edward Tomkinson

Title: Alan Edward Tomkinson: Innovator in Cancer Treatment

Introduction

Alan Edward Tomkinson is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 6 patents, Tomkinson's work focuses on enhancing the efficacy of cancer therapies.

Latest Patents

One of his latest patents is titled "Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells." This invention provides a method for treating subjects suffering from neoplasms, including radiotherapeutic-resistant cancers. The method involves administering a therapeutically effective amount of 5-formyl-2'-deoxyuridine or its derivatives, often in combination with 5-fluorouracil or its prodrugs. Another significant patent involves "Compounds that inhibit human DNA ligases and methods of treating cancer." This patent outlines methods for treating cancer using compounds that inhibit human DNA ligases, providing insights into the mechanisms of DNA repair pathways.

Career Highlights

Throughout his career, Tomkinson has worked with various institutions, including the University of New Mexico and the University System of Maryland. His research has led to advancements in cancer treatment methodologies, showcasing his dedication to improving patient outcomes.

Collaborations

Tomkinson has collaborated with notable colleagues such as Barbara Dziegielewska and Alexander D MacKerell, Jr. These partnerships have further enriched his research and contributed to the development of innovative cancer therapies.

Conclusion

Alan Edward Tomkinson's contributions to cancer treatment through his patents and research collaborations highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in therapeutic strategies against cancer.